Arbor Research Collaborative for Health, Ann Arbor, Michigan, USA.
Clin J Am Soc Nephrol. 2012 Dec;7(12):1977-87. doi: 10.2215/CJN.00390112. Epub 2012 Sep 13.
When hemodialysis dose is scaled to body water (V), women typically receive a greater dose than men, but their survival is not better given a similar dose. This study sought to determine whether rescaling dose to body surface area (SA) might reveal different associations among dose, sex, and mortality.
DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Single-pool Kt/V (spKt/V), equilibrated Kt/V, and standard Kt/V (stdKt/V) were computed using urea kinetic modeling on a prevalent cohort of 7229 patients undergoing thrice-weekly hemodialysis. Data were obtained from the Centers for Medicare & Medicaid Services 2008 ESRD Clinical Performance Measures Project. SA-normalized stdKt/V (SAN-stdKt/V) was calculated as stdKt/V × ratio of anthropometric volume to SA/17.5. Patients were grouped into sex-specific dose quintiles (reference: quintile 1 for men). Adjusted hazard ratios (HRs) for 1-year mortality were calculated using Cox regression.
spKt/V was higher in women (1.7 ± 0.3) than in men (1.5 ± 0.2; P<0.001), but SAN-stdKt/V was lower (women: 2.3 ± 0.2; men: 2.5 ± 0.3; P<0.001). For both sexes, mortality decreased as spKt/V increased, until spKt/V was 1.6-1.7 (quintile 4 for men: HR, 0.62; quintile 3 for women: HR, 0.64); no benefit was observed with higher spKt/V. HR for mortality decreased further at higher SAN-stdKt/V in both sexes (quintile 5 for men: HR, 0.69; quintile 5 for women: HR, 0.60).
SA-based dialysis dose results in dose-mortality relationships substantially different from those with volume-based dosing. SAN-stdKt/V analyses suggest women may be relatively underdosed when treated by V-based dosing. SAN-stdKt/V as a measure for dialysis dose may warrant further study.
当根据体水(V)调整血液透析剂量时,女性通常比男性接受更大的剂量,但在接受相似剂量的情况下,她们的存活率并没有提高。本研究旨在确定根据体表面积(SA)调整剂量是否会揭示剂量、性别和死亡率之间的不同关联。
设计、地点、参与者和测量:使用单池 Kt/V(spKt/V)、平衡 Kt/V 和标准 Kt/V(stdKt/V)通过对接受每周三次血液透析的 7229 例患者进行尿素动力学模型计算。数据来自医疗保险和医疗补助服务中心 2008 年 ESRD 临床绩效衡量项目。SA 标准化 stdKt/V(SAN-stdKt/V)的计算公式为 stdKt/V × 体容与 SA/17.5 的比值。患者按性别分为特定剂量五分位数(男性为五分位数 1)。使用 Cox 回归计算 1 年死亡率的调整后的危险比(HR)。
女性的 spKt/V 高于男性(1.7 ± 0.3 比 1.5 ± 0.2;P<0.001),但 SAN-stdKt/V 较低(女性:2.3 ± 0.2;男性:2.5 ± 0.3;P<0.001)。对于两性,随着 spKt/V 的增加,死亡率降低,直到 spKt/V 为 1.6-1.7(男性五分位数 4:HR,0.62;女性五分位数 3:HR,0.64);更高的 spKt/V 没有带来益处。在两性中,SAN-stdKt/V 较高时,死亡率的 HR 进一步降低(男性五分位数 5:HR,0.69;女性五分位数 5:HR,0.60)。
基于 SA 的透析剂量会导致与基于体积的剂量的剂量-死亡率关系大不相同。基于 SAN-stdKt/V 的分析表明,女性在接受基于 V 的剂量治疗时可能相对剂量不足。SAN-stdKt/V 作为透析剂量的衡量标准可能需要进一步研究。